Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.

Regazzi, Mario; Carvalho, Anna Cristina; Villani, Paola; Matteelli, Alberto

Regazzi, Mario; Carvalho, Anna Cristina; Villani, Paola; Matteelli, Alberto.

Affiliation

Regazzi M; Unit of Clinical and Experimental Pharmacokinetics, Foundation IRCCS Policlinico San Matteo, P.le Golgi 2, 27100, Pavia, Italy, regazzim@smatteo.pv.it.

Clin Pharmacokinet ; 53(6): 489-507, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24777631

Subject(s)

Anti-HIV Agents/therapeutic use; Antitubercular Agents/therapeutic use; HIV Infections/drug therapy; Tuberculosis/drug therapy; Anti-HIV Agents/administration & dosage; Anti-HIV Agents/adverse effects; Antitubercular Agents/administration & dosage; Antitubercular Agents/adverse effects; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction/drug effects; Enzyme Inhibitors/administration & dosage; Enzyme Inhibitors/adverse effects; Enzyme Inhibitors/therapeutic use; HIV Infections/complications; Humans; Mycobacterium tuberculosis/isolation & purification; Rifamycins/administration & dosage; Rifamycins/adverse effects; Rifamycins/therapeutic use; Tuberculosis/complications

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / HIV Infections / Anti-HIV Agents / Antitubercular Agents Limits: Humans Language: En Journal: Clin Pharmacokinet Year: 2014 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google